|
Section a4: patient weight: information unknown/not provided.Section d6b: if explanted, give date: not applicable, as the lens remains implanted.Section h3-other (81): the device was not returned for evaluation as it remains implanted; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.An attempt was made to obtain the missing information; however, no additional information has been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
|
|
It was reported that after the preloaded intraocular lens (iol) was implanted in the right eye (od), the patient initially reported having no issues.However, the patient noted that the vision in the od is getting worse over time.Medical records were received, which provided additional information.Based on pre-operative calculations, the refractive target for the od was plano.The cataract surgery operative report od description included the surgeon's standard pre-operative, intra-operative, and post-op cataract surgery steps which were followed with no complications.No secondary surgical or medical interventions were performed outside of standard of care.On (b)(6), 2022, the patient visual acuity (va) od was 20/20 and intraocular pressure (iop) was 16.On (b)(6), 2022, the original surgeon prescribed inreltys four times a day (qid) and the patient¿s uncorrected (sc) va od was 20/20-1 and iop was 13.On (b)(6), 2022, the patient¿s va sc od was 20/20-1 and iop was 15.The patient was also diagnosed with dry eye syndrome and prescribed artificial tears, one drop qid and as needed.On (b)(6), 2022, the patient¿s od va was 20/20-2.On (b)(6), 2022, the patient was examined by a different doctor and the patient¿s od uncorrected distance (dist sc) va was 20/25 and iop was 19.It was noted uncomplicated iol od, and the surgery looked excellent.It was noted that the od had major spasms and has double vision (monocular diplopia) since (b)(6), 2022.Refraction after the other eye stabilizes after cataract surgery.On (b)(6), 2022, the patient was examined by a different doctor, who reported that the od lens was well centered and optical coherence tomography (oct) was flat, no cell.On (b)(6), 2023, the patient was examined by a different doctor, who reported that the patient was experiencing blurred vision od; od uncorrected distance (dsc) va was 20/25- and iop was 12.Upon examination, the periphery showed no holes or tears, attached, and small, flat choroidal nevus, small nasal.It was determined by two different doctors that the lingering diplopia was due to medical marijuana use and was not neurological, however, the patient still complaints of diplopia.It was noted that the patient has very minimal iritis which will be treated with lotemax 0.5% ophthalmic suspension 1 gtt qid od and atropine sulfate 1% 1 gtt twice a day (bid) od.The patient was also prescribed latanoprost 0.005% ophthalmic solution, 1 drop once a day at bedtime (qhs) od, noted at the (b)(6), 2023 visit.Od va on (b)(6), 2023 was dsc 20/40-2.On (b)(6), 2023, the patient was examined by a different doctor and the patient¿s corrected va was 20/20 both eyes (ou) with pinhole and color vision was 8/8 ou.On (b)(6), 2023, the patient visited a previously seen doctor, and the od va was dsc 20/30- and iop was 14.No further information was provided.
|